Anne Le Bouter

1.2k total citations
8 papers, 192 citations indexed

About

Anne Le Bouter is a scholar working on Infectious Diseases, Ophthalmology and Oncology. According to data from OpenAlex, Anne Le Bouter has authored 8 papers receiving a total of 192 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 1 paper in Ophthalmology and 1 paper in Oncology. Recurrent topics in Anne Le Bouter's work include SARS-CoV-2 and COVID-19 Research (4 papers), COVID-19 Clinical Research Studies (2 papers) and Antimicrobial Resistance in Staphylococcus (2 papers). Anne Le Bouter is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (4 papers), COVID-19 Clinical Research Studies (2 papers) and Antimicrobial Resistance in Staphylococcus (2 papers). Anne Le Bouter collaborates with scholars based in France, Netherlands and United States. Anne Le Bouter's co-authors include Slim Fourati, Roland Leclercq, Sébastien Maury, Vincent Cattoir, Rabah Redjoul, Gilles Thomas, Petra van der Groep, Fred H. Menko, Elsken van der Wall and René H.M. Verheijen and has published in prestigious journals such as Ophthalmology, Journal of Clinical Pathology and Clinical Microbiology and Infection.

In The Last Decade

Anne Le Bouter

8 papers receiving 187 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne Le Bouter France 7 101 53 52 36 26 8 192
Hans-Helmut Niller Germany 7 132 1.3× 28 0.5× 35 0.7× 26 0.7× 14 0.5× 10 205
Emad Behboudi Iran 10 72 0.7× 42 0.8× 43 0.8× 41 1.1× 37 1.4× 39 187
Alisha Dhiman United States 10 28 0.3× 209 3.9× 36 0.7× 49 1.4× 18 0.7× 15 263
Kenneth Doig Australia 7 112 1.1× 118 2.2× 44 0.8× 44 1.2× 11 0.4× 11 319
Mónica L. Acevedo Chile 8 66 0.7× 77 1.5× 49 0.9× 30 0.8× 14 0.5× 17 188
Frithjof Glowinski Germany 4 72 0.7× 99 1.9× 26 0.5× 22 0.6× 62 2.4× 4 222
Yafeng Zheng China 10 30 0.3× 209 3.9× 39 0.8× 19 0.5× 37 1.4× 24 345
Chunlin Zhang China 8 142 1.4× 57 1.1× 45 0.9× 14 0.4× 9 0.3× 15 365
Svilen Tzonev United States 3 36 0.4× 141 2.7× 19 0.4× 36 1.0× 8 0.3× 6 241
Ryutaro Kotaki Japan 9 108 1.1× 90 1.7× 29 0.6× 21 0.6× 103 4.0× 19 264

Countries citing papers authored by Anne Le Bouter

Since Specialization
Citations

This map shows the geographic impact of Anne Le Bouter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Le Bouter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Le Bouter more than expected).

Fields of papers citing papers by Anne Le Bouter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Le Bouter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Le Bouter. The network helps show where Anne Le Bouter may publish in the future.

Co-authorship network of co-authors of Anne Le Bouter

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Le Bouter. A scholar is included among the top collaborators of Anne Le Bouter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Le Bouter. Anne Le Bouter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Leclerc, Mathieu, Rabah Redjoul, Anne Le Bouter, et al.. (2022). Determinants of SARS-CoV-2 waning immunity in allogeneic hematopoietic stem cell transplant recipients. Journal of Hematology & Oncology. 15(1). 27–27. 10 indexed citations
2.
Fourati, Slim, Anne Le Bouter, Fabien Le Bras, et al.. (2022). Anti-SARS-CoV-2 antibody response after 2 and 3 doses of BNT162b2 mRNA vaccine in patients with lymphoid malignancies. Clinical Microbiology and Infection. 28(6). 885.e7–885.e11. 10 indexed citations
3.
Redjoul, Rabah, et al.. (2021). Antibody response after third BNT162b2 dose in recipients of allogeneic HSCT. The Lancet Haematology. 8(10). e681–e683. 49 indexed citations
4.
Fourati, Slim, Alexandre Soulier, Anne Le Bouter, et al.. (2021). Performance of a high-throughput, automated enzyme immunoassay for the detection of SARS-CoV-2 antigen, including in viral “variants of concern”: Implications for clinical use. Journal of Clinical Virology. 146. 105048–105048. 7 indexed citations
5.
Goldschmidt, P., Sandrine Degorge, Djida Ghoubay, et al.. (2012). New Strategy for Rapid Diagnosis and Characterization of Keratomycosis. Ophthalmology. 119(5). 945–950. 15 indexed citations
6.
Bouter, Anne Le. (2011). Infections à Staphylococcus saprophyticus. 13(1). 12–19. 1 indexed citations
7.
Bouter, Anne Le, Roland Leclercq, & Vincent Cattoir. (2010). Molecular basis of resistance to macrolides, lincosamides and streptogramins in Staphylococcus saprophyticus clinical isolates. International Journal of Antimicrobial Agents. 37(2). 118–123. 33 indexed citations
8.
Groep, Petra van der, Anne Le Bouter, Rianne van der Zanden, et al.. (2006). Distinction between hereditary and sporadic breast cancer on the basis of clinicopathological data. Journal of Clinical Pathology. 59(6). 611–617. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026